Affinity Asset Advisors’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-600,000
| Closed | -$5M | – | 96 |
|
|
2024
Q3 | $5M | Buy |
+600,000
| New | +$5M | 0.68% | 39 |
|
|
2024
Q2 | – | Sell |
-450,000
| Closed | -$2.95M | – | 108 |
|
|
2024
Q1 | $2.95M | Buy |
450,000
+384,000
| +582% | +$2.52M | 0.37% | 54 |
|
|
2023
Q4 | $428K | Sell |
66,000
-259,000
| -80% | -$1.68M | 0.08% | 67 |
|
|
2023
Q3 | $1.63M | Buy |
+325,000
| New | +$1.63M | 0.46% | 41 |
|
|
2022
Q3 | – | Sell |
-401,268
| Closed | -$995K | – | 67 |
|
|
2022
Q2 | $995K | Buy |
+401,268
| New | +$995K | 0.42% | 29 |
|